These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Reflections on the "intrathymic pathogenesis" of myasthenia gravis. Hohlfeld R; Wekerle H J Neuroimmunol; 2008 Sep; 201-202():21-7. PubMed ID: 18644632 [TBL] [Abstract][Full Text] [Related]
3. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat. Meinl E; Klinkert WE; Wekerle H Am J Pathol; 1991 Nov; 139(5):995-1008. PubMed ID: 1951638 [TBL] [Abstract][Full Text] [Related]
4. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis. Fujii Y; Hashimoto J; Monden Y; Ito T; Nakahara K; Kawashima Y J Immunol; 1986 Feb; 136(3):887-91. PubMed ID: 2416838 [TBL] [Abstract][Full Text] [Related]
5. Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis. Wakkach A; Guyon T; Bruand C; Tzartos S; Cohen-Kaminsky S; Berrih-Aknin S J Immunol; 1996 Oct; 157(8):3752-60. PubMed ID: 8871679 [TBL] [Abstract][Full Text] [Related]
6. Correlation between acetylcholine receptor antibody levels and thymic pathology in myasthenia gravis: a review. Huang GZ; Lo YL J Clin Neuromuscul Dis; 2013 Jun; 14(4):209-17. PubMed ID: 23703018 [TBL] [Abstract][Full Text] [Related]
7. Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study. Schluep M; Willcox N; Vincent A; Dhoot GK; Newsom-Davis J Ann Neurol; 1987 Aug; 22(2):212-22. PubMed ID: 3662452 [TBL] [Abstract][Full Text] [Related]
8. [Antibodies in myasthenia gravis]. Eymard B Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288 [TBL] [Abstract][Full Text] [Related]
9. Antigenic modulation of junctional acetylcholine receptor is not sufficient to account for the development of myasthenia gravis in receptor immunized mice. Berman PW; Heinemann SF J Immunol; 1984 Feb; 132(2):711-7. PubMed ID: 6690616 [TBL] [Abstract][Full Text] [Related]
10. The myasthenia gravis thymus: a rare source of human autoantibody-secreting plasma cells for testing potential therapeutics. Hill ME; Shiono H; Newsom-Davis J; Willcox N J Neuroimmunol; 2008 Sep; 201-202():50-6. PubMed ID: 18722675 [TBL] [Abstract][Full Text] [Related]
11. Schwann cells and myasthenia gravis. Preferential uptake of soluble and membrane-bound AChR by normal and immortalized Schwann cells, and immunogenic presentation to AChR-specific T line lymphocytes. Zhang YP; Porter S; Wekerle H Am J Pathol; 1990 Jan; 136(1):111-22. PubMed ID: 1688688 [TBL] [Abstract][Full Text] [Related]
12. Myogenesis in thymic transplants in the severe combined immunodeficient mouse model of myasthenia gravis. Differentiation of thymic myoid cells into striated muscle cells. Spuler S; Marx A; Kirchner T; Hohlfeld R; Wekerle H Am J Pathol; 1994 Oct; 145(4):766-70. PubMed ID: 7943168 [TBL] [Abstract][Full Text] [Related]
13. Congenital canine myasthenia gravis: II. Acetylcholine receptor metabolism. Oda K; Lennon VA; Lambert EH; Palmer AC Muscle Nerve; 1984; 7(9):717-24. PubMed ID: 6543920 [TBL] [Abstract][Full Text] [Related]
14. Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. A new model of myasthenia gravis. Schönbeck S; Padberg F; Hohlfeld R; Wekerle H J Clin Invest; 1992 Jul; 90(1):245-50. PubMed ID: 1634612 [TBL] [Abstract][Full Text] [Related]
15. Acetylcholine receptor and thymus in experimental autoimmune myasthenia gravis and experimental myositis. Ueno S; Wada K; Kang J; Takahashi M; Tarui S Clin Exp Immunol; 1982 Dec; 50(3):563-71. PubMed ID: 7165999 [TBL] [Abstract][Full Text] [Related]
16. C5 gene influences the development of murine myasthenia gravis. Christadoss P J Immunol; 1988 Apr; 140(8):2589-92. PubMed ID: 3356901 [TBL] [Abstract][Full Text] [Related]
17. [Role of the thymus in the physiopathology of myasthenia]. Eymard B; Berrih-Aknin S Rev Neurol (Paris); 1995 Jan; 151(1):6-15. PubMed ID: 7676132 [TBL] [Abstract][Full Text] [Related]
18. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis. Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390 [TBL] [Abstract][Full Text] [Related]
19. An acetylcholine receptor alpha subunit promoter confers intrathymic expression in transgenic mice. Implications for tolerance of a transgenic self-antigen and for autoreactivity in myasthenia gravis. Salmon AM; Bruand C; Cardona A; Changeux JP; Berrih-Aknin S J Clin Invest; 1998 Jun; 101(11):2340-50. PubMed ID: 9616205 [TBL] [Abstract][Full Text] [Related]
20. Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis. Poëa-Guyon S; Christadoss P; Le Panse R; Guyon T; De Baets M; Wakkach A; Bidault J; Tzartos S; Berrih-Aknin S J Immunol; 2005 May; 174(10):5941-9. PubMed ID: 15879086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]